Crinetics Pharmaceuticals (CRNX) Prepaid Assets (2017 - 2026)
Crinetics Pharmaceuticals' quarterly Prepaid Assets came in at $22.4 million in Q1 2026, up 36.09% year-on-year from $16.4 million in Q1 2025, and up 547.02% quarter-over-quarter from $3.5 million in Q4 2025.
Crinetics Pharmaceuticals has reported Prepaid Assets for 10 years, with the latest figure at $22.4 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 36.09% year-over-year to $22.4 million; the trailing twelve-month figure through Mar 2026 stood at $22.4 million (up 36.09% YoY), and the FY2025 full-year result was $3.5 million, down 85.39% from the prior year.
- Prepaid Assets for Q1 2026 stood at $22.4 million, up from $3.5 million in the prior quarter.
- The five-year high for Prepaid Assets was $28.5 million in Q3 2025, with the low at $287000.0 in Q2 2022.
- Average Prepaid Assets over 5 years is $8.4 million, with a median of $1.9 million recorded in 2022.
- Year-over-year, Prepaid Assets plunged 96.22% in 2022 and surged 6008.98% in 2025.
- Tracing CRNX's Prepaid Assets over 5 years: stood at $1.9 million in 2022, then sank by 55.6% to $857000.0 in 2023, then jumped by 2659.39% to $23.6 million in 2024, then plunged by 85.39% to $3.5 million in 2025, then jumped by 547.02% to $22.4 million in 2026.
- The last three Prepaid Assets figures came in at $22.4 million (Q1 2026), $3.5 million (Q4 2025), and $28.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.36 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 28.48 Mn |
| Jun 30, 2025 | 20.40 Mn |
| Mar 31, 2025 | 16.43 Mn |
| Dec 31, 2024 | 23.65 Mn |
| Sep 30, 2024 | 14.92 Mn |
| Jun 30, 2024 | 334,000.00 |
| Mar 31, 2024 | 3.56 Mn |
| Dec 31, 2023 | 857,000.00 |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 372,000.00 |
| Mar 31, 2023 | 583,000.00 |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 287,000.00 |
| Mar 31, 2022 | 1.62 Mn |
| Dec 31, 2021 | 912,000.00 |
| Sep 30, 2021 | 10.65 Mn |
| Jun 30, 2021 | 7.59 Mn |
| Mar 31, 2021 | 912,000.00 |
| Dec 31, 2020 | 6.61 Mn |
| Sep 30, 2020 | 659,000.00 |
| Jun 30, 2020 | 5.45 Mn |
| Mar 31, 2020 | 775,000.00 |
| Dec 31, 2019 | 648,000.00 |
| Sep 30, 2019 | 1.48 Mn |
| Jun 30, 2019 | 2.78 Mn |
| Mar 31, 2019 | 1.90 Mn |
| Dec 31, 2018 | 2.81 Mn |
| Sep 30, 2018 | 1.39 Mn |
| Jun 30, 2018 | 313,000.00 |
| Dec 31, 2017 | 239,000.00 |